In the AJCC N2 subgroup—representing LUAD patients with advanced lymph node metastasis—high MCM4 expression was associated with an even higher risk of death, with an HR of 2.53 (Figure 6). The gene discussed is MCM4; the disease is metastatic malignant neoplasm in the lymph nodes.